311 related articles for article (PubMed ID: 8585935)
1. Cytokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy.
Elner SG; Elner VM; Jaffe GJ; Stuart A; Kunkel SL; Strieter RM
Curr Eye Res; 1995 Nov; 14(11):1045-53. PubMed ID: 8585935
[TBL] [Abstract][Full Text] [Related]
2. Interleukin (IL)-6, interleukin (IL)-8 levels and cellular composition of the vitreous humor in proliferative diabetic retinopathy, proliferative vitreoretinopathy, and traumatic proliferative vitreoretinopathy.
Canataroglu H; Varinli I; Ozcan AA; Canataroglu A; Doran F; Varinli S
Ocul Immunol Inflamm; 2005; 13(5):375-81. PubMed ID: 16422002
[TBL] [Abstract][Full Text] [Related]
3. Soluble cellular adhesion molecules in proliferative vitreoretinopathy and proliferative diabetic retinopathy.
Barile GR; Chang SS; Park LS; Reppucci VS; Schiff WM; Schmidt AM
Curr Eye Res; 1999 Sep; 19(3):219-27. PubMed ID: 10487959
[TBL] [Abstract][Full Text] [Related]
4. Chemokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy.
Abu El-Asrar AM; Struyf S; Kangave D; Geboes K; Van Damme J
Eur Cytokine Netw; 2006 Sep; 17(3):155-65. PubMed ID: 17194635
[TBL] [Abstract][Full Text] [Related]
5. Elevated Activating Transcription Factor 4 and Glucose-Regulated 78 Kda Protein Levels Correlate with Inflammatory Cytokines in the Aqueous Humor and Vitreous of Proliferative Diabetic Retinopathy.
Wang Y; Gao S; Zhu Y; Shen X
Curr Eye Res; 2017 Aug; 42(8):1202-1208. PubMed ID: 28497987
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-8, nitric oxide and glutathione status in proliferative vitreoretinopathy and proliferative diabetic retinopathy.
Cicik E; Tekin H; Akar S; Ekmekçi OB; Donma O; Koldaş L; Ozkan S
Ophthalmic Res; 2003; 35(5):251-5. PubMed ID: 12920337
[TBL] [Abstract][Full Text] [Related]
7. Soluble TNF receptors in vitreoretinal proliferative disease.
Limb GA; Hollifield RD; Webster L; Charteris DG; Chignell AH
Invest Ophthalmol Vis Sci; 2001 Jun; 42(7):1586-91. PubMed ID: 11381065
[TBL] [Abstract][Full Text] [Related]
8. Vitreous vascular endothelial growth factor concentrations in proliferative diabetic retinopathy versus proliferative vitreoretinopathy.
Citirik M; Kabatas EU; Batman C; Akin KO; Kabatas N
Ophthalmic Res; 2012; 47(1):7-12. PubMed ID: 21691136
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of RAGE and its ligands in proliferative retinal disease.
Pachydaki SI; Tari SR; Lee SE; Ma W; Tseng JJ; Sosunov AA; Cataldergirmen G; Scarmeas N; Caspersen C; Chang S; Schiff WM; Schmidt AM; Barile GR
Exp Eye Res; 2006 May; 82(5):807-15. PubMed ID: 16364297
[TBL] [Abstract][Full Text] [Related]
10. C-C chemokines in the vitreous of patients with proliferative vitreoretinopathy and proliferative diabetic retinopathy.
Capeans C; De Rojas MV; Lojo S; Salorio MS
Retina; 1998; 18(6):546-50. PubMed ID: 9869464
[TBL] [Abstract][Full Text] [Related]
11. Monocyte chemotactic protein-1 in proliferative vitreoretinal disorders.
Abu el-Asrar AM; Van Damme J; Put W; Veckeneer M; Dralands L; Billiau A; Missotten L
Am J Ophthalmol; 1997 May; 123(5):599-606. PubMed ID: 9152065
[TBL] [Abstract][Full Text] [Related]
12. High-mobility group box-1 and biomarkers of inflammation in the vitreous from patients with proliferative diabetic retinopathy.
El-Asrar AM; Nawaz MI; Kangave D; Geboes K; Ola MS; Ahmad S; Al-Shabrawey M
Mol Vis; 2011; 17():1829-38. PubMed ID: 21850157
[TBL] [Abstract][Full Text] [Related]
13. Angiogenin levels in the vitreous from patients with proliferative diabetic retinopathy.
Ozaki H; Hayashi H; Oshima K
Ophthalmic Res; 1996; 28(6):356-60. PubMed ID: 9032794
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of M-CSF and IL-13 in vitreous of patients with proliferative diabetic retinopathy: implications for M2 macrophage-involving fibrovascular membrane formation.
Yoshida S; Kobayashi Y; Nakama T; Zhou Y; Ishikawa K; Arita R; Nakao S; Miyazaki M; Sassa Y; Oshima Y; Izuhara K; Kono T; Ishibashi T
Br J Ophthalmol; 2015 May; 99(5):629-34. PubMed ID: 25355804
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-8, monocyte chemoattractant protein-1 and IL-10 in the vitreous fluid of patients with proliferative diabetic retinopathy.
Hernández C; Segura RM; Fonollosa A; Carrasco E; Francisco G; Simó R
Diabet Med; 2005 Jun; 22(6):719-22. PubMed ID: 15910622
[TBL] [Abstract][Full Text] [Related]
16. Quantitative analysis of interleukin-6 in vitreous from patients with proliferative vitreoretinal diseases.
Kojima S; Yamada T; Tamai M
Jpn J Ophthalmol; 2001; 45(1):40-5. PubMed ID: 11163044
[TBL] [Abstract][Full Text] [Related]
17. Immunological biomarkers of the vitreous responsible for proliferative alteration in the different forms of retinal detachment.
Balogh A; Milibák T; Szabó V; Nagy ZZ; Kaarniranta K; Resch MD
BMC Ophthalmol; 2020 Dec; 20(1):491. PubMed ID: 33371882
[TBL] [Abstract][Full Text] [Related]
18. Monocyte chemotactic protein-1 in the vitreous of patients with proliferative diabetic retinopathy.
Mitamura Y; Takeuchi S; Matsuda A; Tagawa Y; Mizue Y; Nishihira J
Ophthalmologica; 2001; 215(6):415-8. PubMed ID: 11741107
[TBL] [Abstract][Full Text] [Related]
19. Levels of pentosidine in the vitreous of eyes with proliferative diabetic retinopathy, proliferative vitreoretinopathy and retinal detachment.
Tomé CC; De Rojas Silva MV; Rodríguez-García J; Rodríguez-Segade S; Sánchez-Salorio M
Graefes Arch Clin Exp Ophthalmol; 2005 Dec; 243(12):1272-6. PubMed ID: 15947940
[TBL] [Abstract][Full Text] [Related]
20. Monocyte chemotactic protein-1 levels in the vitreous of patients with proliferative vitreoretinopathy.
Mitamura Y; Takeuchi S; Yamamoto S; Yamamoto T; Tsukahara I; Matsuda A; Tagawa Y; Mizue Y; Nishihira J
Jpn J Ophthalmol; 2002; 46(2):218-21. PubMed ID: 12062231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]